Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia

Clinical research in adrenocortical carcinoma includes postoperative adjuvant therapy, treatment of advanced and metastatic disease, and maintenance strategies after initial response to systemic therapy. The sponsor’s studies also address combinations built around mitotane, etoposide, cisplatin, and immunotherapy.

• High-risk postoperative management
• Advanced and metastatic disease control
• Maintenance immunotherapy

Interest extends across recurrence prevention, disease stabilization, and therapy intensification in adrenal malignancy.